Christopher S. Hackett
Impact in
Papers in
-
- CRISPR and Genetic Engineering 3
- Protein Degradation and Inhibitors 2
-
- Neuroblastoma Research and Treatments 5
- Co-authors
- Renier J. Brentjens (3 shared papers)Sarwish Rafiq (3 shared papers)William A. Weiss (10 shared papers)Philipp Strittmatter (5 shared papers)Juris Ozols (3 shared papers)Qi-Wen Fan (1 shared paper)Theodore Nicolaides (1 shared paper)Christine Cheng (1 shared paper)
- Journals
- Journal of Biological Chemistry (5 papers)Cancer Research (3 papers)The Journal of Infectious Diseases (2 papers)Molecular Therapy (1 paper)Nature Reviews Clinical Oncology (1 paper)
- Partner nations
- United StatesUnited KingdomCanada
In The Last Decade
Christopher S. Hackett
25 papers receiving 2.2k citations
Christopher S. Hackett's Hit Papers
Peers
Comparison fields: 5 of 104
- Oncology 1.1k
- Genetics 256
- Immunology 504
- Molecular Biology 1.1k
- Cancer Research 227
Countries citing papers authored by Christopher S. Hackett
This map shows the geographic impact of Christopher S. Hackett's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher S. Hackett with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher S. Hackett more than expected).
Fields of papers citing papers by Christopher S. Hackett
This network shows the impact of papers produced by Christopher S. Hackett. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher S. Hackett. The network helps show where Christopher S. Hackett may publish in the future.
Co-authors
The 25 scholars most cited alongside Christopher S. Hackett, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Engineering strategies to overcome the current roadblocks in CAR T cell therapy Hit paper breakdown → | 2019 | 1030 |
| 2 | 2007 | 160 | |
| 3 | 2012 | 156 | |
| 4 | Genetic determinants of malignancy in a mouse model for oligodendroglioma. | 2003 | 129 |
| 5 | 1995 | 91 | |
| 6 | Genome-wide array CGH analysis of murine neuroblastoma reveals distinct genomic aberrations which parallel those in human tumors. | 2003 | 90 |
| 7 | 2012 | 67 | |
| 8 | 1996 | 64 | |
| 9 | 2012 | 63 | |
| 10 | 2006 | 60 | |
| 11 | 2009 | 59 | |
| 12 | 1984 | 44 | |
| 13 | 2007 | 43 | |
| 14 | 1990 | 39 | |
| 15 | 1988 | 37 | |
| 16 | 2007 | 29 | |
| 17 | 1986 | 28 | |
| 18 | 1988 | 18 | |
| 19 | 1981 | 17 | |
| 20 | 2022 | 15 |
About Christopher S. Hackett
Christopher S. Hackett is a scholar working on Molecular Biology, Neurology, Oncology, Pediatrics, Perinatology and Child Health and Genetics, having authored 25 papers that have together received 2.3k indexed citations. Recurring topics across this work include Neuroblastoma Research and Treatments (5 papers), CAR-T cell therapy research (5 papers), Neonatal Health and Biochemistry (4 papers), CRISPR and Genetic Engineering (3 papers), Cancer, Hypoxia, and Metabolism (3 papers), Protein Degradation and Inhibitors (2 papers), Nanowire Synthesis and Applications (2 papers) and Virus-based gene therapy research (2 papers). The work is most often cited by research in Oncology (1.1k citations), Genetics (256 citations), Immunology (504 citations), Molecular Biology (1.1k citations) and Cancer Research (227 citations). Christopher S. Hackett has collaborated with scholars based in United States, United Kingdom and Canada. Frequent co-authors include Renier J. Brentjens, Sarwish Rafiq, William A. Weiss, Philipp Strittmatter, Juris Ozols, Qi-Wen Fan, Theodore Nicolaides, Christine Cheng, Kevan M. Shokat and Zachary A. Knight. Their work appears in journals such as Journal of Biological Chemistry, Cancer Research, The Journal of Infectious Diseases, Molecular Therapy and Nature Reviews Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.